Zobrazeno 1 - 10
of 101
pro vyhledávání: '"William, Novotny"'
This book is a clinical guide in the practice of pediatric critical care and can serve as a roadmap for an introductory journey through this broad and challenging subspecialty. Key topics intrinsic to the practice of pediatric critical care are addre
Autor:
Song Mu, Borje Darpo, Zhiyu Tang, William Novotny, Manal Tawashi, Hongqi Xue, Michael Willett, Leo Lin, Sri Sahasranaman, Ying C. Ou
Publikováno v:
Clinical and Translational Science, Vol 13, Iss 5, Pp 923-931 (2020)
This thorough QT (TQT) study evaluated the effect of zanubrutinib on electrocardiogram (ECG) parameters by using concentration‐QTc (C‐QTc) analysis as the primary analysis for this study. Part A of the study determined the safety and tolerability
Externí odkaz:
https://doaj.org/article/e0ea160c88114e70927aa41ba7867992
Autor:
Wei Xu, Shenmiao Yang, Keshu Zhou, Ling Pan, Zengjun Li, Jianfeng Zhou, Sujun Gao, Daobin Zhou, Jianda Hu, Ru Feng, Haiwen Huang, Meng Ji, Haiyi Guo, Jane Huang, William Novotny, Shibao Feng, Jianyong Li
Publikováno v:
Journal of Hematology & Oncology, Vol 13, Iss 1, Pp 1-12 (2020)
Abstract Background Bruton tyrosine kinase (BTK) inhibitors have demonstrated a high degree of efficacy in the treatment of B cell malignancies characterized by constitutive B cell receptor activation, including chronic lymphocytic leukemia/small lym
Externí odkaz:
https://doaj.org/article/d68ce5ec7b0f4b0586ac59532d098a28
Autor:
David H. Johnson, Roy S. Herbst, Corey J. Langer, Louis Fehrenbacher, William Novotny, Eric Holmgren, Jacques Gaudreault, John Nemunaitis, David M. Jablons, Fairooz F. Kabbinavar, Russell F. DeVore, Lisa A. Damico
Publikováno v:
Journal of Clinical Oncology. 41:2305-2312
Purpose To investigate the efficacy and safety of bevacizumab plus carboplatin and paclitaxel in patients with advanced or recurrent non-small-cell lung cancer. Patients and Methods In a phase II trial, 99 patients were randomly assigned to bevacizum
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::186a6cc4f094b6d28c76ddac63f92a21
https://doi.org/10.1200/jco.22.02543
https://doi.org/10.1200/jco.22.02543
Autor:
Wei Xu, Shenmiao Yang, Keshu Zhou, Ling Pan, Zengjun Li, Sujun Gao, Daobin Zhou, Jianda Hu, Ru Feng, Haiwen Huang, Tingyu Wang, Dengju Li, Meng Ji, Haiyi Guo, Xia Zhao, Binghao Wu, Yiling Yu, Yu Wang, Jane Huang, William Novotny, Jianyong Li
Publikováno v:
Leukemia & Lymphoma. 64:712-716
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5d073631f2df02b9de2dd257210d7056
https://doi.org/10.1080/10428194.2022.2164692
https://doi.org/10.1080/10428194.2022.2164692
Autor:
Takayuki Ishikawa, Masahiro Takeuchi, Kazuyuki Shimada, Kohmei Kubo, Takeshi Kondo, Katsuya Fujimoto, Tomoaki Fujisaki, Koji Nagafuji, Rika Sakai, Shingo Kurahashi, Tatsuro Jo, Kazutaka Sunami, Senji Kasahara, Tomonori Nakazato, Haiyi Guo, William Novotny, Chris Tankersley, Motohisa Takai, Hui Yao, Jinhua Zhong, Hongjie Zhu, Koji Izutsu
Publikováno v:
Blood. 140:3663-3665
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a1f989f0d3ddb2f839d02fd3a361787e
https://doi.org/10.1182/blood-2022-168696
https://doi.org/10.1182/blood-2022-168696
Autor:
Mary-Ellen Taplin, Alison Hannah, Andrew Krivoshik, Gabriel P. Haas, Adam Kibel, Rosina T. Lis, Alvin M. Matsumoto, Peter S. Nelson, Steven P. Balk, Stephen Plymate, Brett T. Marck, Philip W. Kantoff, Kenneth Wu, William Novotny, Martin Sanda, Daniel W. Lin, Kim N. Chi, Elahe A. Mostaghel, Glenn J. Bubley, Neil Fleshner, Martin E. Gleave, Anthony M. Joshua, Maria S. Tretiakova, Bruce Montgomery
Purpose: Prostate cancer is dependent on androgen receptor (AR) activation. Optimal AR antagonism may effectively cytoreduce local disease and suppress or eliminate micrometastases. We evaluated neoadjuvant therapy prior to prostatectomy with the pot
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::667ec97dbaa7d0a2df25a461f5daae76
https://doi.org/10.1158/1078-0432.c.6525576.v1
https://doi.org/10.1158/1078-0432.c.6525576.v1
Autor:
Jun Zhu, Rachel Wei, William Novotny, Jane Huang, Rebecca Elstrom, Lei Zhou, Haiyi Guo, Sujun Gao, Ru Feng, Fangfang Lv, Jie Jin, Wei Xu, Jie Ji, Huilai Zhang, Haiyan Yang, Jianda Hu, Jianfeng Zhou, Dehui Zou, Keshu Zhou, Yuqin Song
Kaplan-Meier Plots Comparing Duration of Response (A) and Progression-Free Survival (B) Among Patients With and Without TP53-Mutated Tumors
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c3350387923b11bdd0e3112874b21835
https://doi.org/10.1158/1078-0432.22476563
https://doi.org/10.1158/1078-0432.22476563
Autor:
Mark T. Fleming, Howard I. Scher, Taoufik Ouatas, Zakaria Khondker, Amy C. Peterson, Jacqueline A. Gibbons, William Novotny, Dana E. Rathkopf, Michael J. Morris
Supplemental Table 1. Reasons for docetaxel discontinuation Supplemental Figure 1. Safety and PK assessment schedule
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::be43aefda7a2aa5f81d20cae72db4fc3
https://doi.org/10.1158/1078-0432.22454636
https://doi.org/10.1158/1078-0432.22454636
Autor:
Jun Zhu, Rachel Wei, William Novotny, Jane Huang, Rebecca Elstrom, Lei Zhou, Haiyi Guo, Sujun Gao, Ru Feng, Fangfang Lv, Jie Jin, Wei Xu, Jie Ji, Huilai Zhang, Haiyan Yang, Jianda Hu, Jianfeng Zhou, Dehui Zou, Keshu Zhou, Yuqin Song
Appendix Tables 1-2
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1bf42dda2b68f8abfbd5fdd72d722eb0
https://doi.org/10.1158/1078-0432.22476572.v1
https://doi.org/10.1158/1078-0432.22476572.v1